The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder

Background and objective: Children with attention-deficit hyperactivity disorder (ADHD) experience difficulty with expressive language, including form (e.g. grammatical construction) and content (e.g. coherence). The current study aimed to investigate the effect of methylphenidate-Osmotic Release Or...

Full description

Bibliographic Details
Main Authors: Tessa L. Rausch, Diane L. Kendall, Sara T. Kover, Elizabeth M. Louw, Ursula L. Zsilavecz, Anita van der Merwe
Format: Article
Language:English
Published: AOSIS 2017-02-01
Series:South African Journal of Communication Disorders
Subjects:
Online Access:https://sajcd.org.za/index.php/sajcd/article/view/180
id doaj-24713527f0874ae9a5779586181710eb
record_format Article
spelling doaj-24713527f0874ae9a5779586181710eb2020-11-24T23:37:55ZengAOSISSouth African Journal of Communication Disorders0379-80462225-47652017-02-01641e1e1210.4102/sajcd.v64i1.180451The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorderTessa L. Rausch0Diane L. Kendall1Sara T. Kover2Elizabeth M. Louw3Ursula L. Zsilavecz4Anita van der Merwe5Department of Speech-Language Pathology and Audiology, University of PretoriaDepartment of Speech-Language Pathology and Audiology, University of Pretoria, South Africa; Department of Speech and Hearing Sciences, University of Washington, United StatesDepartment of Speech and Hearing Sciences, University of WashingtonDepartment of Statistics, University of PretoriaDepartment of Speech-Language Pathology and Audiology, University of PretoriaDepartment of Speech-Language Pathology and Audiology, University of PretoriaBackground and objective: Children with attention-deficit hyperactivity disorder (ADHD) experience difficulty with expressive language, including form (e.g. grammatical construction) and content (e.g. coherence). The current study aimed to investigate the effect of methylphenidate-Osmotic Release Oral System® (MPH-OROS®) on the narrative ability of children with ADHD and language impairment, through the analysis of microstructure and macrostructure narrative elements. Method: In a single group off–on medication test design, narratives were obtained from 12 children with ADHD, aged 7–13 years, using wordless picture books. For microstructure, number of words, type–token ratio and mean length of utterance were derived from narrative samples using Systematic Analysis of Language Transcripts conventions. For macrostructure, the narratives were coded according to the Narrative Scoring Scheme, which includes seven narrative characteristics, as well as a composite score reflecting the child’s overall narrative ability. Results: The administration of MPH-OROS® resulted in a significant difference in certain aspects of language macrostructure: cohesion and overall narrative ability. Little effect was noted in microstructure elements. Conclusion: We observed a positive effect of stimulant medication on the macrostructure, but not on the microstructure, of narrative production. Although stimulant medication improves attention and concentration, it does not improve all aspects of language abilities in children with ADHD. Language difficulties associated with ADHD related to language content and use may be more responsive to stimulant medication than language form, which is likely to be affected by cascading effects of inattention, hyperactivity and impulsivity beginning very early in life and to progress over a more protracted period. Therefore, a combination of treatments is advocated to ensure that children with ADHD are successful in reaching their full potential.https://sajcd.org.za/index.php/sajcd/article/view/180Attention-deficit hyperactivity disorderstimulant medicationnarrativespeech-language therapychildren
collection DOAJ
language English
format Article
sources DOAJ
author Tessa L. Rausch
Diane L. Kendall
Sara T. Kover
Elizabeth M. Louw
Ursula L. Zsilavecz
Anita van der Merwe
spellingShingle Tessa L. Rausch
Diane L. Kendall
Sara T. Kover
Elizabeth M. Louw
Ursula L. Zsilavecz
Anita van der Merwe
The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder
South African Journal of Communication Disorders
Attention-deficit hyperactivity disorder
stimulant medication
narrative
speech-language therapy
children
author_facet Tessa L. Rausch
Diane L. Kendall
Sara T. Kover
Elizabeth M. Louw
Ursula L. Zsilavecz
Anita van der Merwe
author_sort Tessa L. Rausch
title The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder
title_short The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder
title_full The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder
title_fullStr The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder
title_full_unstemmed The effect of methylphenidate-OROS<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder
title_sort effect of methylphenidate-oros<sup>®</sup> on the narrative ability of children with attention-deficit hyperactivity disorder
publisher AOSIS
series South African Journal of Communication Disorders
issn 0379-8046
2225-4765
publishDate 2017-02-01
description Background and objective: Children with attention-deficit hyperactivity disorder (ADHD) experience difficulty with expressive language, including form (e.g. grammatical construction) and content (e.g. coherence). The current study aimed to investigate the effect of methylphenidate-Osmotic Release Oral System® (MPH-OROS®) on the narrative ability of children with ADHD and language impairment, through the analysis of microstructure and macrostructure narrative elements. Method: In a single group off–on medication test design, narratives were obtained from 12 children with ADHD, aged 7–13 years, using wordless picture books. For microstructure, number of words, type–token ratio and mean length of utterance were derived from narrative samples using Systematic Analysis of Language Transcripts conventions. For macrostructure, the narratives were coded according to the Narrative Scoring Scheme, which includes seven narrative characteristics, as well as a composite score reflecting the child’s overall narrative ability. Results: The administration of MPH-OROS® resulted in a significant difference in certain aspects of language macrostructure: cohesion and overall narrative ability. Little effect was noted in microstructure elements. Conclusion: We observed a positive effect of stimulant medication on the macrostructure, but not on the microstructure, of narrative production. Although stimulant medication improves attention and concentration, it does not improve all aspects of language abilities in children with ADHD. Language difficulties associated with ADHD related to language content and use may be more responsive to stimulant medication than language form, which is likely to be affected by cascading effects of inattention, hyperactivity and impulsivity beginning very early in life and to progress over a more protracted period. Therefore, a combination of treatments is advocated to ensure that children with ADHD are successful in reaching their full potential.
topic Attention-deficit hyperactivity disorder
stimulant medication
narrative
speech-language therapy
children
url https://sajcd.org.za/index.php/sajcd/article/view/180
work_keys_str_mv AT tessalrausch theeffectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT dianelkendall theeffectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT saratkover theeffectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT elizabethmlouw theeffectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT ursulalzsilavecz theeffectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT anitavandermerwe theeffectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT tessalrausch effectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT dianelkendall effectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT saratkover effectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT elizabethmlouw effectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT ursulalzsilavecz effectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
AT anitavandermerwe effectofmethylphenidateorossupsuponthenarrativeabilityofchildrenwithattentiondeficithyperactivitydisorder
_version_ 1725518411397595136